Viewing Study NCT01836861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-02-21 @ 7:21 AM
Study NCT ID: NCT01836861
Status: COMPLETED
Last Update Posted: 2021-03-17
First Post: 2013-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: IPI-145 ADME and Absolute Bioavailability Study
Sponsor: SecuraBio
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None healthy male volunteers View
None ADME View
None Bioavailability View
None PI3K inhibitor View
None Absorption View
None Distribution View
None Metabolism View
None Excretion View
None safety View